Navigation Links
Vapotherm Closes Financing Round, Appoints James Liken as Chairman of the Board and Opens New Corporate Headquarters

EXETER, N.H., April 24, 2013 /PRNewswire-USNewswire/ -- On April 12, 2013 Vapotherm closed a $29MM financing round which was led by the 3x5 Special Opportunity Fund L.P. and included new investor Morgenthaler Venture Partners L.P.  Existing investors GE Asset Management, Kaiser Permanente, Integral Capital Partners, QuestMark Partners and Cross Creek Capital also participated in the current round. The proceeds from this financing will be used to fund the Company's growth plans.

Tony Arnerich , General Partner of the 3x5 Special Opportunity Fund, and Jason Lettmann , Principal of Morgenthaler Venture Partners, both join the Board of Directors.

"We are delighted to be a part of the Vapotherm story," said Tony Arnerich , General Partner of the 3x5 Special Opportunity Fund.  "The unique technology and its clinical benefit for patients with a wide variety of breathing disorders is what appealed to our group. We look forward to supporting the Company and its management team."

James "Jim" Liken, a board member since April 2010, has agreed to serve as Chairman of the Board of Directors.  Jim has extensive experience with respiratory technology companies, including Respironics Inc. where he served as President and CEO from August 1999 through December 2003 and as Vice Chairman until March 2008.

"I have been part of the team for almost three years and am pleased to serve in this new capacity.  This is a very exciting time for Vapotherm," said Jim Liken.

Bill Niland , Founder of Vapotherm said, "We appreciate the support of new investors 3x5 and Morgenthaler and our existing investors, as well as Jim's commitment to serve as Chairman of the Board.  He brings a wealth of knowledge and experience to our organization."

In addition to closing the financing Vapotherm opened new corporate headquarters in Exeter, New Hampshire at the start of the year.  The facility, located at 22 Industrial Drive, incorporates 14,400 square feet of office space and 12,000 square feet of manufacturing space. 

"One of the key reasons for moving corporate headquarters to Exeter was to have access to the New England medtech industry, including suppliers, partners, and the deep talent pool," said Joe Army , President and CEO of Vapotherm.  "We look forward to expanding our operations in the New Hampshire seacoast region and having a positive impact in the community."

Vapotherm, Inc. is a privately held manufacturer of advanced respiratory care devices based in Exeter, New Hampshire.  The company develops innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders.  Over 500,000 patients have been treated with Vapotherm high flow therapy.  For more information, visit

John Landry , CFO (603) 658-0011

SOURCE Vapotherm, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
2. InspireMD Closes $25 Million Underwritten Public Offering
3. Inovio Pharmaceuticals Closes $15.1 Million Offering of Common Stock and Warrants
4. PTC Therapeutics Closes $60 Million Private Financing
5. Spring Bank Pharmaceuticals Closes $10.5 million Series A Financing to fund Phase I Clinical Trials in HCV-infected Patients
6. Sphere Fluidics Successfully Closes a $2.5 million Series A Investment Round
7. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
8. Aethlon Medical Discloses CEO Interview
9. Wright Therapy Products, Inc. Closes $3 million Financing Round
10. Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease Program
11. Edison Pharmaceuticals Closes $20M Series F Financing
Post Your Comments:
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
Breaking Medicine News(10 mins):